Cynata Therapeutics Limited ( (AU:CYP) ) has issued an announcement. Cynata Therapeutics Limited announced it received a $1.7 million R&D Tax Incentive Refund for the 2024/2025 financial year. This ...

On track for top-line trial results in the third quarter of 2026 from pivotal Phase 2b clinical trial ELPIS II. ELPIS II is evaluating ...

ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy ® (epinephrine ...

Wang X^, Zhao J^, Marostica E, Yuan W, Jin J, Zhang J, Li R, Tang H, Wang K, Li Y, Wang F, Peng Y, Zhu J, Zhang J, Jackson CR, Zhang J, Dillon D, Lin NU, Sholl L ...

Onlymyhealth is a resource-house of health information and medical updates on healthy life ideas. Get closer to healthy living with the help of expert advice on weight loss, cancer health, pregnancy, ...

Mina is a molecular biology major and plans to become an oncologist, with a focus on improving access to care.

Compared with the standard of care, an AI-based ECG model greatly reduced false positives for ST-elevation myocardial ...

In the week following the announcement of this acquisition, Sanro Health, Inc. is reported to have made an investment in ...